ClassID:

20247

A61K31/202 - page 9 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic

Recent Application in this class:
#2401
20090234008
2009-09-17

Method of using catalpic acid to treat dyslipidemia

#2402
20090234007
2009-09-17

Unsaturated Fatty Acids as Thrombin Inhibitors

#2403
20090233862
2009-09-17

Compositions and methods for treatment of optic nerve diseases

#2404
20090226481
2009-09-10

Compositions ameliorating a reduced diurnal activity and/or depressive symptoms

#2405
20090222951
2009-09-03

Method for producing polyunsaturated fatty acids in transgenic plants

#2406
20090221486
2009-09-03

METHOD FOR TREATING AND/OR PREVENTING INFECTIONS IN INFANTS DELIVERED VIA CAESAREAN SECTION

#2407
20090220639
2009-09-03

Preventing diseases in infants delivered via caesarean section

#2408
20090220562
2009-09-03

Osteogenic and anti-adipogenic oxysterols

#2409
20090215897
2009-08-27

Method for treatment and prevention of respiratory insufficiency

#2410
20090209644
2009-08-20

Lipotoxicity relieving agent

#2411
20090209601
2009-08-20

USE OF RXR AGONISTS FOR THE TREATMENT OF OSTEOARTHRITIS

#2412
20090203788
2009-08-13

Method of enhancing reproductive function of mammals by feeding of conjugated linoleic acids

#2413
20090203787
2009-08-13

Very long chain polyunsaturated fatty acids, methods of production, and uses

#2414
20090203780
2009-08-13

Use of a Polyunsaturated Fatty Acid Compound

#2415
20090203655
2009-08-13

PROPHYLACTIC DOCOSAHEXAENOIC ACID THERAPY FOR PATIENTS WITH SUBCLINICAL INFLAMMATION

#2416
20090202668
2009-08-13

Use of a polyphenol in the treatment of the metabolic syndrome and endothelial dysfunction or other vascular sequellae

#2417
20090197955
2009-08-06

METHODS OF IMPROVING DHA DEPOSITION AND RELATED FUNCTION AND/OR DEVELOPMENT

#2418
20090196861
2009-08-06

Biocompatible Latent Emulsifiers

#2419
20090192226
2009-07-30

Materials and Methods for Treatment of Pathological Ocular Vascular Proliferation

#2420
20090192126
2009-07-30

Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin

#2421
20090186803
2009-07-23

USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID, SPHINGOLIPID AND CHOLESTEROL.

#2422
20090182050
2009-07-16

Salts of Fatty Acids and Methods of Making and Using thereof

#2423
20090182049
2009-07-16

Pharmaceutical Composition and Method for Treating Hypertriglyceridemia and Hypercholesterolemia in Humans

#2424
20090182022
2009-07-16

Treatment of Fatty Liver

#2425
20090181974
2009-07-16

Composition for slowing down the development of alzheimer's disease

#2426
20090181437
2009-07-16

Method for producing a conjugated linoleic acid glyceride

#2427
20090181154
2009-07-16

Non-allergenic ingredients and food products

#2428
20090181109
2009-07-16

Nanoveso™: treatment, biomarkers and diagnostic tests for liver diseases and comorbid diseases

#2429
20090176862
2009-07-09

Use of a RAR antagonist or inverse agonist for the treatment of chemotherapy and/or radiation therapy side effects

#2430
20090170816
2009-07-02

COMBINATION COMPRISING SQUALENE, A PHOSPHOLIPID AND AN OMEGA 3 FATTY ACID FOR THE TREATMENT OF CANCER

#2431
20090162323
2009-06-25

Method for Stimulating the Intestinal Flora

#2432
20090156675
2009-06-18

Composition for preventing the occurrence of cardiovascular event in multiple risk patient

#2433
20090156673
2009-06-18

Anti-inflammatory actions of neuroprotectin D1/protectin D1 and it's natural stereoisomers

#2434
20090156487
2009-06-18

Infant nutritional compositions for preventing obesity

#2435
20090149539
2009-06-11

PET FOOD COMPOSITIONS AND METHODS

#2436
20090143468
2009-06-04

PET FOOD COMPOSITIONS AND METHODS

#2437
20090142314
2009-06-04

MATERNAL SUPPLEMENT

#2438
20090137527
2009-05-28

Compositions and methods for modulating immune function

#2439
20090136615
2009-05-28

Nutrition with lipids and non-digestible saccharides

#2440
20090136460
2009-05-28

USE OF ADENOSINE RECEPTOR LIGANDS TO PROMOTE CELL ADHESION IN CELL-BASED THERAPIES

#2441
20090130219
2009-05-21

Composition for Improving Lipid Metabolism

#2442
20090118525
2009-05-07

Reduction of sterols and other compounds from oils

#2443
20090118243
2009-05-07

Compositions and methods for the treatment of ophthalmic conditions

#2444
20090118228
2009-05-07

CAROTENOID-CONTAINING COMPOSITIONS AND METHODS

#2445
20090111877
2009-04-30

Methods for enhancing the quality of life of a senior animal

#2446
20090111777
2009-04-30

Jelly composition

#2447
20090105343
2009-04-23

Cancer Therapy And Medicaments Therefor

#2448
20090105342
2009-04-23

PUFA SUPPLEMENTS

#2449
20090104283
2009-04-23

METHOD FOR REDUCING THE SEVERITY OF NEUROLOGICAL DISORDERS

#2450
20090099261
2009-04-16

Omega-3 mixtures

#2451
20090099259
2009-04-16

Method for regulating gene expression

#2452
20090093514
2009-04-09

Immune response modifier formulations containing oleic acid and methods

#2453
20090082448
2009-03-26

Method for placental exfoliation using oxo-arachidonic acid or the like

#2454
20090082447
2009-03-26

Pharmaceutical Compositions Containing Omega 3 Fatty Acids

#2455
20090081179
2009-03-26

Method for reducing the severity of neurological disorders

#2456
20090076129
2009-03-19

Methods and related compositions using specific indanes to reduce weight and inhibit lipase, α-amylase and α-glucosidase activity in mammals

#2457
20090074857
2009-03-19

Glycerophospholipids for the improvement of cognitive functions

#2458
20090069425
2009-03-12

Active composition for treatment or prevention of problems related to a disturbance of the biological clock

#2459
20090069424
2009-03-12

TGF-alpha expression inhibitors

#2460
20090068190
2009-03-12

ANTI-PROLIFERATIVE COMBINATIONS

#2461
20090061067
2009-03-05

METHOD FOR MAKING KRILL MEAL

#2462
20090061048
2009-03-05

Delivery and controlled release of encapsulated lipophilic nutrients

#2463
20090054523
2009-02-26

Use of a Fatty Acid Composition Containing DHA for the Production of a Medical Product or a Food Stuff for the Treatment of Amyloidos-Related Diseases

#2464
20090054329
2009-02-26

COMPOSITION WITH DOCOSAPENTAENOIC ACID

#2465
20090048215
2009-02-19

Compositions for Ameliorating a Reduced Higher Brain Function Resulting From Organic Brain Lesions

#2466
20090042979
2009-02-12

Novel Statin Pharmaceutical Compositions and Related Methods of Treatment

#2467
20090028963
2009-01-29

Polyphenol coxib combinations and methods

#2468
20090023692
2009-01-22

COMPOSITIONS FOR INHIBITING AND PREVENTING VASCULAR OCCLUSION CONTAINING NUTRITIONAL SUPPLEMENTS

#2469
20090022813
2009-01-22

Composition for improving membrane composition and functioning of cells

#2470
20090018186
2009-01-15

STABLE BEVERAGE PRODUCTS COMPRISING POLYUNSATURATED FATTY ACID EMULSIONS

#2471
20090018125
2009-01-15

Pharmaceutical Composition and Its Use

#2472
20090016991
2009-01-15

Rxr Antagonist Treatment Against Multiple Sclerosis

#2473
20090012167
2009-01-08

Omega-3 Fatty Acids and Dyslipidemic Agent for Lipid Therapy

#2474
20090012166
2009-01-08

Oligomers of straight-chain and unbranched fatty acids and drugs containing these

#2475
20090010968
2009-01-08

Spot-on formulation useful for cosmetology and dermatology

#2476
20080317868
2008-12-25

Composition for improving membrane composition and functioning cells

#2477
20080306157
2008-12-11

Therapeutic intervention to MIMIC the effect of caloric restriction

#2478
20080306156
2008-12-11

Method of using catalpic acid to treat hyperinsulinemia

#2479
20080306155
2008-12-11

METHOD FOR TREATING RENAL DISEASE

#2480
20080306154
2008-12-11

Treatment and prevention of major adverse cardiovascular events or major coronary evens by administering Omega-3 fatty acids

#2481
20080300297
2008-12-04

Taxane derivative containing pharmaceutical composition with improved therapeutic efficacy

#2482
20080292724
2008-11-27

COMPOSITION FOR IMPROVING MEMBRANE COMPOSITION AND FUNCTIONING CELLS

#2483
20080292681
2008-11-27

Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage

#2484
20080292649
2008-11-27

Composition for improving membrane composition and functioning of cells

#2485
20080292613
2008-11-27

Food Supplement Based on Group B Vitamins, Trace Elements and -3 and/or 6- Fatty Acids and Use of This Food Supplement in the Simultaneous Treatment of Localized Cellulite and Slackening of the Skin

#2486
20080280980
2008-11-13

Treatment and prevention of bone loss using resolvins

#2487
20080275119
2008-11-06

Treatment and prevention of liver disease associated with parenteral nutrition (PN)

#2488
20080274203
2008-11-06

Bioeffective krill oil compositions

#2489
20080269331
2008-10-30

Use of polyunsaturated fatty acids for the primary prevention of major cardiovascular events

#2490
20080269330
2008-10-30

Nutrition containing fat blend

#2491
20080268042
2008-10-30

OMEGA 3 FATTY ACID FORMULATIONS

#2492
20080267890
2008-10-30

Anti-microbial agent

#2493
20080260859
2008-10-23

Composition Containing Omega-3 Fatty Acids and Omega-6 Fatty Acids

#2494
20080254188
2008-10-16

FORMULATIONS OF LIPOPHILIC BIOACTIVE MOLECULES

#2495
20080254152
2008-10-16

Methods for Reducing the Effects of Stress on Skin Condition

#2496
20080254012
2008-10-16

Nutritional formulation for promoting catch-up growth

#2497
20080242729
2008-10-02

Rxr Antagonists in the Treatment of Inflammatory Diseases

#2498
20080241292
2008-10-02

COMPOSITION AND METHOD FOR WEIGHT LOSS

#2499
20080241076
2008-10-02

Method and composition for increasing Erythropoietin

#2500
20080234377
2008-09-25

POLYUNSATURATED FATTY ACIDS FOR TREATMENT OF DEMENTIA AND PRE-DEMENTIA-RELATED CONDITIONS

#2501
20080234362
2008-09-25

Treatment for Asthma and Arthritis and Other Inflammatory Diseases

#2502
20080226745
2008-09-18

Products containing highly unsaturated fatty acids for use by women during stages of preconception, pregnancy and lactation/post-partum

#2503
20080220486
2008-09-11

Method for growing photosynthetic organisms

#2504
20080214665
2008-09-04

Approach to anti-microbial host defense with molecular shields with lipoxin compounds

#2505
20080214652
2008-09-04

Methods of treating hyperlipidemia

#2506
20080214618
2008-09-04

Gastric Therapies Amd Compositions Therefor

#2507
20080213239
2008-09-04

Fatty acid formulations and methods of use thereof

#2508
20080213236
2008-09-04

Natural Remedy-Dietary Supplement Combination Product

#2509
20080207748
2008-08-28

VITAMIN C PREPARATION

#2510
20080206213
2008-08-28

Method for reducing or preventing systemic inflammation

#2511
20080206212
2008-08-28

Method for the utilization of and product containing inactivated probiotic

#2512
20080200707
2008-08-21

Lipotoxicity Relieving Agent

#2513
20080200547
2008-08-21

Highly purified ethyl EPA and other EPA derivatives

#2514
20080199923
2008-08-21

Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids

#2515
20080193561
2008-08-14

Preparation for the prevention and/or treatment of vascular disorders

#2516
20080176964
2008-07-24

AGENTS WHICH REGULATE, INHIBIT, OR MODULATE THE ACTIVITY AND/OR EXPRESSION OF CONNECTIVE TISSUE GROWTH FACTOR (CTGF) AS A UNIQUE MEANS TO BOTH LOWER INTRAOCULAR PRESSURE AND TREAT GLAUCOMATOUS RETINOPATHIES/OPTIC NEUROPATHIES

#2517
20080176944
2008-07-24

Elongase genes and uses thereof

#2518
20080171084
2008-07-17

Pharmaceutical semi-solid composition of isotretinoin

#2519
20080167382
2008-07-10

Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases

#2520
20080166780
2008-07-10

Process for the Heterotrophic Production of Microbial Products with High Concentrations of Omega-3 Highly Unsaturated Fatty Acids

#2521
20080161275
2008-07-03

Compositions and methods for the treatment of inflammatory disease

#2522
20080161274
2008-07-03

Compounds and methods for inhibition of bone loss

#2523
20080160108
2008-07-03

Method of treating muscular dystrophies with an inhibitor of histone deacetylase

#2524
20080153909
2008-06-26

COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS AND CONDITIONS

#2525
20080153831
2008-06-26

ISOFLAVONE-CONTAINING COMPOSITIONS FOR THE TREATMENT OF OSTEOPOROSIS AND INFLAMMATORY JOINT DISEASE

#2526
20080152726
2008-06-26

Method for reducing the severity of neurological disorders

#2527
20080152725
2008-06-26

Methods and kits for co-administration of nutritional supplements

#2528
20080146664
2008-06-19

Method for treating diseases caused by accumulation of body fat

#2529
20080125490
2008-05-29

Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids

#2530
20080124323
2008-05-29

Nutritional composition comprising indigestible oligosaccharides

#2531
20080119553
2008-05-22

Activators of peroxisome proliferator-activated receptors

#2532
20080119439
2008-05-22

Treatment and prevention of intestinal fibrosis

#2533
20080114066
2008-05-15

Synergistic Effects Of Docosahexaenoic Acid (DHA) And Carotenoid Absorption Of Cognitive Function

#2534
20080113046
2008-05-15

Use of Omega-3 Fatty Acid(s) for Treating Hypercholesterolemia Caused by Anti-Retroviral Treatment of Hiv-Infected Patients

#2535
20080108699
2008-05-08

Composition comprising dihomo-γ-linolenic acid (DGLA) as active ingredient

#2536
20080107638
2008-05-08

Methods of attenuating autoimmune disease and compositions useful therefor

#2537
20080102131
2008-05-01

PARTICULATE COMPOSITION COMPRISING BIOACTIVE SUBSTANCE AND METHOD OF PRODUCING THE SAME

#2538
20080096961
2008-04-24

Use of docosatrienes, resolvins and their stable analogs in the treatment of airway diseases and asthma

#2539
20080089876
2008-04-17

Composition containing statins and omega-3 fatty acids

#2540
20080085911
2008-04-10

STATIN AND OMEGA-3 FATTY ACIDS FOR REDUCTION OF APO-B LEVELS

#2541
20080081840
2008-04-03

Meal replacement compositions and weight control method

#2542
20080076823
2008-03-27

Methods of improving bone health and muscle health

#2543
20080075786
2008-03-27

Antimicrobial agents derived from cream

#2544
20080064749
2008-03-13

Lipoxin Analogs as Novel Inhibitors of Angiogenesis

#2545
20080064746
2008-03-13

Lipoxins and Aspirin-Triggered Lipoxins and Their Stable Analogs in the Treatment of Asthma and Inflammatory Airway Diseases

#2546
20080064656
2008-03-13

Intestinal barrier integrity

#2547
20080064635
2008-03-13

Infant Formulas for Early Brain Development

#2548
20080058418
2008-03-06

STABLE POLYUNSATURATED FATTY ACID EMULSIONS AND METHODS FOR INHIBITING, SUPPRESSING, OR REDUCING DEGRADATION OF POLYUNSATURATED FATTY ACIDS IN AN EMULSION

#2549
20080045594
2008-02-21

Use of at Least One Conjugated Triene-Containing Fatty Acid for Preparing a Medicine for Treating Inflammation

#2550
20080032957
2008-02-07

Cytotropic heterogeneous molecular lipids (CHML), method of preparation, and methods of treating patients with multiple cancers

#2551
20080031967
2008-02-07

Compositions, products and methods for controlling weight in a mammal

#2552
20080031814
2008-02-07

NON-ALLERGENIC INGREDIENTS AND FOOD PRODUCTS

#2553
20080021105
2008-01-24

Medicine Capable of Inhibiting Activation of Transcription Factor Klf5

#2554
20080015166
2008-01-17

Barrier Integrity in Hiv Patients

#2555
20080003330
2008-01-03

Infant formulas for early brain development

#2556
20070298079
2007-12-27

Food fortified with omega-3 fatty acids

#2557
20070286838
2007-12-13

Tamanu oil products

#2558
20070274983
2007-11-29

Nutritional composition comprising immunoglobulins and oligosaccharides

#2559
20070270493
2007-11-22

Composition with Preventive or Improvement Effect on Stress-Induced Brain Function Impairment and Related Symptoms or Diseases

#2560
20070270376
2007-11-22

Combinations of Hyaluronic Acid and Polyunsaturated Fatty Acids

#2561
20070269507
2007-11-22

Type A gelatin capsule containing PUFA in free acid form

#2562
20070265341
2007-11-15

COMPOSITIONS AND METHODS FOR TREATING EYE DISORDERS AND CONDITIONS

#2563
20070265340
2007-11-15

Treatment of fatty liver

#2564
20070264222
2007-11-15

ENHANCED PROTECTION AGAINST SKIN INJURY IN HUMANS

#2565
20070259957
2007-11-08

Jelly composition

#2566
20070259051
2007-11-08

Method of treating a condition associated with phosphorylation of TASK-1

#2567
20070254954
2007-11-01

Composition with preventive or improvement effect on symptoms or diseases associated with stress-induced behavior disorders

#2568
20070254897
2007-11-01

Compositions and methods for the treatment of cardiovascular disease

#2569
20070253943
2007-11-01

Compositions for Topical Treatment

#2570
20070237780
2007-10-11

Method of preventing or reducing the risk or incidence of cancer

#2571
20070232579
2007-10-04

Nitrated lipids and methods of making and using thereof

#2572
20070231361
2007-10-04

Use of Fatty Acids to Inhibit the Growth of Aneurysms

#2573
20070225370
2007-09-27

Nutritional Compositions and Methods

#2574
20070219271
2007-09-20

Pharmaceutical Compositions Containing Pufa And At Least One Of An Immunosuppressive Agent Or An Antineoplastic Agent

#2575
20070218105
2007-09-20

Topical Treatment with NGF and DHA in Damaged Corneas

#2576
20070212427
2007-09-13

Hormone replacement formulation

#2577
20070212380
2007-09-13

Conjugated fatty acid based emulsion and methods for preparing and using same

#2578
20070208043
2007-09-06

Use of serum amyloid A gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents

#2579
20070207975
2007-09-06

Materials and methods for treating and preventing Her-2/neu overexpressing, FAS-elevated cancer cells

#2580
20070207223
2007-09-06

Means for improving cardiovascular health

#2581
20070203238
2007-08-30

Method for preventing or reducing elevated triglyceride levels

#2582
20070203237
2007-08-30

Method for preventing or treating obesity

#2583
20070203235
2007-08-30

Method for preventing or treating anemia

#2584
20070203074
2007-08-30

Composition and method for the efficacious and safe administration of halopyruvate for the treatment of cancer

#2585
20070202194
2007-08-30

Preparation for the prevention and/or treatment of vascular disorders

#2586
20070202153
2007-08-30

Liquid Concentrated Formula

#2587
20070202052
2007-08-30

Method for increasing the expression of pulmonary surfactant protein-B

#2588
20070197606
2007-08-23

USE OF PPAR AGONISTS AS ANTI-OXIDANTS

#2589
20070196505
2007-08-23

Compositions and methods for improving skin health and pelage quality

#2590
20070196465
2007-08-23

Treatment with dihydropyridine calcium channel blockers and omega-3 fatty acids and a combination product thereof

#2591
20070196446
2007-08-23

Conjugated fatty acid esters

#2592
20070196445
2007-08-23

Method for the Prevention and Treatment of Cachexia and Anorexia

#2593
20070191483
2007-08-16

Method of enhancing reproductive function of mammals by feeding of conjugated linoleic acids

#2594
20070191467
2007-08-16

STATIN AND OMEGA-3 FATTY ACIDS FOR LIPID THERAPY

#2595
20070185201
2007-08-09

Compositions and methods for treating feline inflammatory bowel disease

#2596
20070184090
2007-08-09

PUFA supplements

#2597
20070167509
2007-07-19

Use of phenserine and analogs to treat behavioral problems and improve trainability

#2598
20070167479
2007-07-19

Immune response modifier formulations and methods

#2599
20070166417
2007-07-19

Formulation and Methods for Use of Morinda Citrifolia Seed Oil

#2600
20070166413
2007-07-19

Cholestrol-reducing agent containing an n-3 fatty acid

#2601
20070166411
2007-07-19

Nutritional supplement containing long-chain polyunsaturated fatty acids

#2602
20070161705
2007-07-12

Use of highly concentrated compositions of selected n-3 fatty acids for the treatment of central nervous system disturbances

#2603
20070160591
2007-07-12

Peri-operative and peri-procedure nutritional supplementation

#2604
20070160590
2007-07-12

Metabolic uncoupling therapy

#2605
20070154432
2007-07-05

Compositions and methods for hair growth

#2606
20070149617
2007-06-28

USE OF AN OMEGA-3 LIPID-BASED EMULSION FOLLOWING ISCHEMIC INJURY TO PROVIDE PROTECTION AND RECOVERY IN HUMAN ORGANS

#2607
20070141138
2007-06-21

Omega 3 fatty acid formulations

#2608
20070135376
2007-06-14

METHOD TO REDUCE OXIDATIVE DAMAGE AND IMPROVE MITOCHONDRIAL EFFICIENCY

#2609
20070134198
2007-06-14

Composition and use of RAR antagonists for promoting chondrogenesis

#2610
20070123588
2007-05-31

Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements

#2611
20070123558
2007-05-31

Immune response modifier formulations containing oleic acid and methods

#2612
20070122452
2007-05-31

Fat composition

#2613
20070112071
2007-05-17

Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof

#2614
20070105954
2007-05-10

Formulation containing a carboxylic acid or an ester thereof

#2615
20070105949
2007-05-10

Intermediates for the preparation of lipoxin Aanalogs

#2616
20070104805
2007-05-10

Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives

#2617
20070104779
2007-05-10

Treatment with omega-3 fatty acids and products thereof

#2618
20070104700
2007-05-10

Nutritional formula for optimal gut barrier function

#2619
20070099996
2007-05-03

Pharmaceutical compositions of acitretin

#2620
20070099279
2007-05-03

Microorganisms that extracellularly secrete lipid particles encapsulating lipids

#2621
20070098808
2007-05-03

Krill extracts for treatment of cardiovascular diseases

#2622
20070098787
2007-05-03

Composition for preventing and treating varicose veins of lower extremities

#2623
20070087957
2007-04-19

Methods and compositions for oral administration of proteins

#2624
20070082949
2007-04-12

Agent for preventing and treating language disorders

#2625
20070082384
2007-04-12

Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids

#2626
20070082374
2007-04-12

Method of treating a condition associated with phosphorylation of task-1

#2627
20070082065
2007-04-12

Therapeutic composition for the treatment of dry eye syndrome

#2628
20070082063
2007-04-12

Risk assessment and correction of membrane damage of the upper GI tract

#2629
20070077638
2007-04-05

Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms

#2630
20070077637
2007-04-05

Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms

#2631
20070060651
2007-03-15

Compositions and methods for improving functional vascular cellular survival integrity and reducing apoptosis in ischemia

#2632
20070059297
2007-03-15

Methods and compositions for improving visual acuity

#2633
20070053955
2007-03-08

Compositions and methods for improving cellular survival and reducing apoptosis after ischemic episode in the brain

#2634
20070049569
2007-03-01

Methods of using fatty-acid esters of estrogens and thermogenic compounds for reducing the body weight of a mammal and compositions containing the same

#2635
20070042953
2007-02-22

Antiepileptogenic complex of albumin with docosahexaenoate

#2636
20070037887
2007-02-15

Blockade of mtor to prevent a hormonal adaptive response

#2637
20070037869
2007-02-15

Histone deacetylase inhibitors

#2638
20070037864
2007-02-15

Intermediates for the preparation of lipoxin Aanalogs

#2639
20070036862
2007-02-15

Treatment with azetidinone-based cholesterol absorption inhibitors and omega-3 fatty acids and a combination product thereof

#2640
20070036737
2007-02-15

PRODUCTS FOR TOPICAL APPLICATION COMPRISING LYSOPHOSPHOLIPIDS AND FATTY ACIDS

#2641
20070032548
2007-02-08

Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions

#2642
20070032546
2007-02-08

Formulations comprising fenofibrate and a statin, and related methods of treatment

#2643
20070031537
2007-02-08

Infant or follow-on formula

#2644
20070026049
2007-02-01

Method of increasing lean body mass and reducing body fat mass in infants

#2645
20070021504
2007-01-25

Composition and/or method for preventing onset and/or recurrence of cardiovascular events

#2646
20070009495
2007-01-11

Method for treating or preventing systemic inflammation in formula-fed infants

#2647
20070009445
2007-01-11

Aerosol compositions and methods

#2648
20070004802
2007-01-04

Method for treating renal disease

#2649
20070004678
2007-01-04

Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes

#2650
20070004639
2007-01-04

Methods and compositions for treating Parkinson's disease

#2651
20070004626
2007-01-04

Methods and compositions for treating degenerative bone disorders

#2652
20060293288
2006-12-28

Use of resolvins to treat gastrointestinal diseases

#2653
20060292633
2006-12-28

Method for modulating process mediated by farnesoid activated receptors

#2654
20060292217
2006-12-28

Nutritional supplement and soft gelatin capsule delivery system

#2655
20060289834
2006-12-28

External composition containing Unsaturated fatty acid or its salt or ester

#2656
20060287256
2006-12-21

Nutraceutical compositions and use thereof

#2657
20060286184
2006-12-21

Composition containing as the active ingredient componantes from salvia sclarea seed

#2658
20060281815
2006-12-14

Conjugated linolenic acids and methods of preparation and purification and uses thereof

#2659
20060276373
2006-12-07

Neuroprotective complex for treatment of cerebral ischemia and injury

#2660
20060270739
2006-11-30

Synergistic effects of docosahexaenoic acid (DHA) and carotenoid absorption on macular pigmentation

#2661
20060270645
2006-11-30

Agents and methods for enhancing bone formation

#2662
20060257530
2006-11-16

Fortified cereal bran to promote digestive health

#2663
20060257454
2006-11-16

Conjugated fatty acid esters

#2664
20060252833
2006-11-09

Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders

#2665
20060252699
2006-11-09

Method for lowering serum homocysteine

#2666
20060246115
2006-11-02

Nutritional products for ameliorating symptoms of rheumatoid arthritis

#2667
20060241130
2006-10-26

Anti-inflammatory compositions and uses thereof

#2668
20060233762
2006-10-19

Method for treating or preventing systemic inflammation in formula-fed infants

#2669
20060229366
2006-10-12

Method for preventing or treating respiratory infections in infants

#2670
20060228403
2006-10-12

Nutritional supplements for cardiovascular health

#2671
20060228384
2006-10-12

Control of biofilm with a biofilm inhibitor

#2672
20060222628
2006-10-05

Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses

#2673
20060217386
2006-09-28

Nutritional preparations

#2674
20060217385
2006-09-28

Nutritional preparations

#2675
20060217355
2006-09-28

Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating cancer

#2676
20060217303
2006-09-28

Compounds and Methods for Treating Seizure Disorders

#2677
20060211763
2006-09-21

Treatment with Statin and Omega-3 Fatty Acids and a Combination Product Thereof

#2678
20060211762
2006-09-21

Omega-3 fatty acids and dyslipidemic agent for lipid therapy

#2679
20060211749
2006-09-21

Treatment with omega-3 fatty acids and PPAR agonist and/or antagonist and a combination product thereof

#2680
20060210568
2006-09-21

Methods and compositions for cancer treatment

#2681
20060205703
2006-09-14

Stabilized steroid composition and method for its preparation

#2682
20060194973
2006-08-31

Trans carotenoids, their synthesis, formulation and uses

#2683
20060193824
2006-08-31

Methods for the treatment of infectious and inflammatory airway diseases

#2684
20060178436
2006-08-10

Use of docosahexanoic acid as active substance for the treatment of lipodystrophy

#2685
20060178347
2006-08-10

Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

#2686
20060177920
2006-08-10

Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids

#2687
20060173077
2006-08-03

Surgical method

#2688
20060172978
2006-08-03

Method of neutralising organoboronates with acids

#2689
20060172920
2006-08-03

Oxidised lipids as reversal agents for boronic acid drugs

#2690
20060172023
2006-08-03

Use of pinolenic acid

#2691
20060166935
2006-07-27

Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction

#2692
20060160898
2006-07-20

Method of using catalpic acid to treat type 2 diabetes and associated disorders

#2693
20060160203
2006-07-20

Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids

#2694
20060159746
2006-07-20

Compositions comprising fatty acids and amino acids

#2695
20060154980
2006-07-13

IMPROVED COX-2 INHIBITORY COMPOSITIONS AND THERAPEUTIC REGIMEN

#2696
20060154908
2006-07-13

Co-administration of dehydroepiandrosterone (DHEA) congeners and other active agents for treating depression

#2697
20060153940
2006-07-13

Use of physiologically active fatty acids

#2698
20060153939
2006-07-13

Method of obtaining and treating compounds from ozonized unsaturated vegetable oils for pharmaceutical compositions for medical and veterinary use

#2699
20060153926
2006-07-13

Compositions, products and methods for controlling weight in a mammal

#2700
20060148684
2006-07-06

Use of a histone deacetylase inhibitor for treating muscular dystrophies